| FORTREA HOLDINGS DL-,001 |
| USA |
| Gesundheit |
| US34965K1079 / A3ECGB |
| K67 (Frankfurt) / FTRE (NASDAQ) |
| FRA:K67, ETR:K67, K67:GR, NASDAQ:FTRE |
| - |
| https://ir.fortrea.com/ |
|
Fortrea Holdings Inc. is a global contract research organization (CRO) providing comprehensive clinical development solutions to biopharmaceutical, biotechnology, and medical device companies worldwide. It specializes in Phase I through IV clinical t..
>Volltext.. |
| 770.31 Mio. EUR |
| 1571.48 Mio. EUR |
| 2359.32 Mio. EUR |
| 43.84 Mio. EUR |
| -854.36 Mio. EUR |
| -9.45 EUR |
| 966.81 Mio. EUR |
| 151.26 Mio. EUR |
| 98.33 Mio. EUR |
| 0.19 |
| -10.98% |
| -181.4% |
| - |
| - |
| - |
| FORTREA |
| 03.04.26 |
|